Table 4. Pharmacokinetic Assessment of Synthesized Thioflavone and Thioflavonol Analogues (2a–2p)a.
compound No. | molecular formula | molecular weight (g/mol) | No. HBAb | No. HBDc | molecular LogPd | molecular LogSe (mg/L) | molecular PSAf A2 | drug-likeness model score | Lipinski’s rule of 5 |
---|---|---|---|---|---|---|---|---|---|
2a | C17H1279Br2O3S | 453.8874 | 4 | 0 | 5.86 | 0.64 | 23.80 | –0.15 | No |
2b | C15H779Br2NO3S | 438.8513 | 4 | 0 | 5.16 | 1.43 | 46.80 | –0.67 | No |
2c | C19H1079Br2OS | 443.8819 | 2 | 0 | 7.48 | 0.03 | 8.27 | –0.46 | No |
2d | C17H1279Br2OS | 421.8976 | 2 | 0 | 6.90 | 0.41 | 8.45 | –0.55 | No |
2e | C15H779Br2ClOS | 427.8273 | 2 | 0 | 6.92 | 0.04 | 8.54 | –0.20 | No |
2f | C13H679Br2OS2 | 399.8227 | 3 | 0 | 5.78 | 0.30 | 9.56 | –0.57 | No |
2g | C24H1579Br2NO3S2 | 586.8860 | 4 | 0 | 8.15 | 0.30 | 37.64 | –0.40 | No |
2h | C16H1079Br2O2S | 423.8768 | 3 | 1 | 5.69 | 0.88 | 22.20 | –0.29 | No |
2i | C19H1079Br2O2S | 459.8768 | 3 | 1 | 6.41 | 0.06 | 21.93 | –0.31 | No |
2j | C24H1579Br2NO4S2 | 602.8809 | 5 | 1 | 7.08 | 0.52 | 51.30 | –0.27 | No |
2k | C17H1279Br2O2S | 437.8925 | 3 | 1 | 6.06 | 1.14 | 22.20 | –0.42 | No |
2l | C17H1379Br2NO2S | 452.9034 | 3 | 1 | 5.31 | 3.38 | 25.01 | –0.36 | No |
2m | C15H779Br235ClO2S | 443.8222 | 3 | 1 | 5.84 | 0.23 | 22.20 | –0.08 | No |
2n | C15H779Br2NO4S | 454.8463 | 5 | 1 | 4.09 | 17.51 | 60.46 | –0.58 | Yes |
2o | C15H779Br2NO4S | 454.8463 | 5 | 1 | 4.11 | 12.78 | 60.46 | –0.44 | Yes |
2p | C17H1279Br2O4S | 469.8823 | 5 | 1 | 4.79 | 7.14 | 37.46 | –0.02 | Yes |
The table above depicts all of Lipinski’s RO5 components.
Number of hydrogen-bond acceptors.
Number of hydrogen-bond donors.
Octanol–Water partition coefficient.
Measured solubility.
Total polar surface area.